Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in Spain
Àngela Domínguez, Núria Soldevila, Diana Toledo, Núria Torner, Luis Force, María José Pérez, Vicente Martín, Lourdes Rodríguez-Rojas, Jenaro Astray, Mikel Egurrola, Francisco Sanz, Jesús Castilla, J. M. Mayoral, J. Díaz-Borrego, A. Morillo, J. Gutiérrez, M. Pérez-Ruiz, M. A. Fernández-Sierra, S. Tamames, S. Rojo-RelloR. Ortiz De Lejarazu, M. I. Fernández-Natal, T. Fernández-Villa, A. Pueyo, V. Martin, A. Vilella, M. Campins, A. Antón, G. Navarro, M. Riera, E. Espejo, M. D. Mas, R. Pérez, J. A. Cayla, C. Rius, P. Godoy, C. Izquierdo, R. Torra, I. Crespo, M. F. Domínguez-Berjon, M. A. Gutiérrez, S. Jiménez, E. Gil, F. Martín, R. Génova-Maleras, M. C. Prados, F. Enzzine De Blas, M. A. Salvador, J. Rodríguez, M. Romero, J. C. Galán, E. Navas, C. J. Álvarez, E. Banderas, S. Fernandez, J. Chamorro, I. Casado, J. Díaz, M. J. López De Goicoechea, M. Morales-Suárez-Varela
Fingerprint
Dive into the research topics of 'Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in Spain'. Together they form a unique fingerprint.